UGT2B15 (UDP glucuronosyltransferase family 2 member B15)

2007-02-01  

Identity

HGNC
LOCATION
4q13.2
LOCUSID
ALIAS
HLUG4,UDPGT

Other Information

Locus ID:

NCBI: 7366
MIM: 600069
HGNC: 12546
Ensembl: ENSG00000196620

Variants:

dbSNP: 7366
ClinVar: 7366
TCGA: ENSG00000196620
COSMIC: UGT2B15

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000196620ENST00000338206P54855

Expression (GTEx)

0
10
20
30
40
50
60
70
80

Pathways

PathwaySourceExternal ID
Pentose and glucuronate interconversionsKEGGko00040
Ascorbate and aldarate metabolismKEGGko00053
Steroid hormone biosynthesisKEGGko00140
Retinol metabolismKEGGko00830
Porphyrin and chlorophyll metabolismKEGGko00860
Metabolism of xenobiotics by cytochrome P450KEGGko00980
Drug metabolism - cytochrome P450KEGGko00982
Drug metabolism - other enzymesKEGGko00983
Pentose and glucuronate interconversionsKEGGhsa00040
Ascorbate and aldarate metabolismKEGGhsa00053
Steroid hormone biosynthesisKEGGhsa00140
Retinol metabolismKEGGhsa00830
Porphyrin and chlorophyll metabolismKEGGhsa00860
Metabolism of xenobiotics by cytochrome P450KEGGhsa00980
Drug metabolism - cytochrome P450KEGGhsa00982
Drug metabolism - other enzymesKEGGhsa00983
Metabolic pathwaysKEGGhsa01100
Glucuronate pathway (uronate pathway)KEGGM00014
Chemical carcinogenesisKEGGhsa05204
Chemical carcinogenesisKEGGko05204
Glucuronate pathway (uronate pathway)KEGGhsa_M00014
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase II conjugationREACTOMER-HSA-156580
GlucuronidationREACTOMER-HSA-156588

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA156ESR1GeneLiterature, MultilinkAnnotationassociated24879639
PA166114434sipoglitazarChemicalClinicalAnnotation, VariantAnnotationassociatedPKPD22960998, 23444281
PA166123026progression-free survivalDiseaseVariantAnnotationnot associatedPD15952058
PA166123207overall survivalDiseaseVariantAnnotationnot associatedPD15952058
PA166123366event-free survivalDiseaseVariantAnnotationassociatedPD23842856
PA166127658Recurrence free survivalDiseaseVariantAnnotationnot associatedPD
PA166131338tamoxifen-n-glucuronideChemicalMultilinkAnnotationnot associated27098059
PA443560Breast NeoplasmsDiseaseVariantAnnotationambiguousPD15952058, 23842856
PA445208PainDiseaseClinicalAnnotationassociatedPD30908574
PA448015acetaminophenChemicalClinicalAnnotation, Literature, MultilinkAnnotation, Pathway, VariantAnnotationassociatedPKPD16696573, 26049587, 30908574
PA450267lorazepamChemicalClinicalAnnotation, PathwayassociatedPK15961980
PA450731oxazepamChemicalClinicalAnnotation, PathwayassociatedPK15044558, 29737521
PA450911phenobarbitalChemicalPathwayassociated26049587
PA450947phenytoinChemicalPathwayassociated26049587
PA451581tamoxifenChemicalVariantAnnotationambiguousPD15952058, 23842856
PA452621antineoplastic agentsChemicalVariantAnnotationambiguousPD15952058, 23842856

References

Pubmed IDYearTitleCitations
356266642022Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.1
356266642022Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action.1
326603552021Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.3
326603552021Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.3
320862972020Coordinated Regulation of UGT2B15 Expression by Long Noncoding RNA LINC00574 and hsa-miR-129-5p in HepaRG Cells.5
321760752020The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients.4
320862972020Coordinated Regulation of UGT2B15 Expression by Long Noncoding RNA LINC00574 and hsa-miR-129-5p in HepaRG Cells.5
321760752020The correlation between UDP-glucuronosyltransferase polymorphisms and environmental endocrine disruptors levels in polycystic ovary syndrome patients.4
293672762018Regulation of UDP-Glucuronosyltransferase 2B15 by miR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites.7
300669172018Bioinformatic analysis suggests that UGT2B15 activates the Hippo‑YAP signaling pathway leading to the pathogenesis of gastric cancer.7
293672762018Regulation of UDP-Glucuronosyltransferase 2B15 by miR-331-5p in Prostate Cancer Cells Involves Canonical and Noncanonical Target Sites.7
300669172018Bioinformatic analysis suggests that UGT2B15 activates the Hippo‑YAP signaling pathway leading to the pathogenesis of gastric cancer.7
288825662017Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.3
289628352017Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.14
288825662017Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.3

Citation

Dessen P

UGT2B15 (UDP glucuronosyltransferase family 2 member B15)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46029/ugt2b15-(udp-glucuronosyltransferase-family-2-member-b15)